Portal de Periódicos da CAPES

The Choice Will Be Tailored TAVR Therapy

2015; Elsevier BV; Volume: 66; Issue: 7 Linguagem: Inglês

10.1016/j.jacc.2015.06.1083

1558-3597

Giuseppe Bruschi, Federico De Marco,

Cardiovascular Function and Risk Factors

The talent is in the choices. —Robert De Niro [(1)][1] The first balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) was first tested in 1992 by Andersen et al. [(2)][2] in an animal model. The subsequent initial human implantation of a BE equine pericardial leaflet stent